Many of the world's most essential medicines are wholly or partly developed in academic laboratories. Their accessibility to the poor in developing countries is profoundly affected by the research, licensing and patenting decisions made by universities.
As members of these institutions of higher learning, we believe that universities have an opportunity and a responsibility to improve access to affordable medicines--particularly those they have helped develop--throughout the world.